Tailoring of Bilosomal Nanogel for Augmenting the Off-Label Use of Sildenafil Citrate in Pediatric Pulmonary Hypertension-Reference-Cited by-同舟云学术

Tailoring of Bilosomal Nanogel for Augmenting the Off-Label Use of Sildenafil Citrate in Pediatric Pulmonary Hypertension

Published:2024-04-20 Issue:17 Volume:9 Page:19536-19547
ISSN:2470-1343
Container-title:ACS Omega
language:en
Short-container-title:ACS Omega

Author:

Almutairy Bjad K.¹,Khafagy El-Sayed¹²^ORCID,Aldawsari Mohammed F.¹,Alshetaili Abdullah¹,Alotaibi Hadil Faris³,Abu Lila Amr Selim⁴⁵⁶

Affiliation:

1. Department of Pharmaceutics, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al-kharj 11942, Saudi Arabia

2. Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Suez Canal University, Ismailia 41522, Egypt

3. Department of Pharmaceutical Sciences, College of Pharmacy, Princess Nourah Bint AbdulRahman University, P.O. Box 84428, Riyadh 11671, Saudi Arabia

4. Department of Pharmaceutics, College of Pharmacy, University of Hail, Hail 81442, Saudi Arabia

5. Medical and Diagnostic Research Center, University of Hail, Hail 81442, Saudi Arabia

6. Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Zagazig University, Zagazig 44519, Egypt

Funder

Prince Sattam bin Abdulaziz University

Princess Nourah Bint Abdulrahman University

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acsomega.4c01133

Reference47 articles.

1. Treatment of pulmonary arterial hypertension by vardenafil-solid dispersion lozenges as a potential alternative drug delivery system

2. Sildenafil in the treatment of erectile dysfunction: an overview of the clinical evidence

3. Sildenafil for Pulmonary Arterial Hypertension

4. Sildenafil in pediatric pulmonary arterial hypertension